Immunology and Microbiology
Inflammatory Arthritis
100%
Methotrexate
33%
TNF Inhibitor
31%
DNA Methylation
18%
Adalimumab
16%
Arthritis
13%
Disease-Modifying Antirheumatic Drug
10%
T-Helper Cell
9%
Gene Expression
9%
Methylation
9%
Tumor Necrosis Factor
8%
Genetic Risk
8%
Etanercept
7%
Epigenetics
6%
Quantitative Trait Locus
6%
Transcriptome
6%
Signal Transduction
6%
Lymphocyte
6%
Interleukin-18 Receptor
6%
Quantitative Trait
6%
Protein Expression
6%
Single Nucleotide Polymorphism
6%
Pharmacogenetics
6%
Erythrocyte Sedimentation Rate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
81%
Tumor Necrosis Factor Inhibitor
32%
Biological Marker
26%
Adalimumab
23%
Methotrexate
21%
Disease Activity Score
15%
Disease Modifying Antirheumatic Drug
15%
Etanercept
13%
Disease
11%
Calgranulin
6%
Tumor Necrosis Factor
6%
Transcriptome
6%
Pharmacokinetics
6%
Biosimilar Agent
6%
Biological Product
5%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
32%
Methotrexate
24%
TNF Inhibitor
18%
Methylation
16%
CD4
13%
B Cell
10%
Gene Expression
9%
Adalimumab
8%
Genetic Risk
8%
Lymphocyte
7%
T Cell
6%
Expression Quantitative Trait Loci
6%
Epigenome
6%
Quantitative Trait Locus
6%
Comorbidity
6%
Quantitative Trait
6%
Missense
6%
Calgranulin
6%
Transcriptome
6%
C-Reactive Protein
6%
Etanercept
6%
Proteomics
6%
Tumor Necrosis Factor
6%
